{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "North Chicago",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65851",
      "recalling_firm": "AbbVie Inc.",
      "address_1": "1401 Sheridan Rd",
      "address_2": "N/A",
      "postal_code": "60064-1803",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-901-2013",
      "product_description": "Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only,  Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA",
      "product_quantity": "704 bottles",
      "reason_for_recall": "Labeling: Incorrect Package Insert; product packaged with outdated version of the insert",
      "recall_initiation_date": "20130801",
      "center_classification_date": "20130820",
      "termination_date": "20131107",
      "report_date": "20130828",
      "code_info": "Lot 22033GY"
    }
  ]
}